Schwerg Marius, Stockburger Martin, Schulze Christoph, Bondke Hansjürgen, Poller Wolfram C, Lembcke Alexander, Melzer Christoph
Department of Cardiology and Angiology, Charité - Universitätsmedizin, Berlin, Germany.
Pacing Clin Electrophysiol. 2014 Oct;37(10):1291-6. doi: 10.1111/pace.12431. Epub 2014 May 30.
Postoperative lead perforation is a life-threatening complication of cardiac pacing. Identification of precipitating factors for this serious complication may help to anticipate a specific risk profile and to minimize the incidence.
We conducted a retrospective tertiary referral center analysis to clarify clinical, anatomical, and technical characteristics related to pacemaker (PM) and cardioverter/defibrillator lead perforation. We examined the baseline characteristics and the symptoms. In a subgroup, we investigated the myocardial thickness on contrast-enhanced cardiac computed tomography.
We enrolled 26 patients. Female gender appears to put patients at slightly increased risk for lead perforation. In a majority active fixation leads were used. Symptoms occurred in 72%. Pericardial effusion and tamponade were present in 38% and 19%, respectively. Sensing was compromised in 65%. A high pacing threshold or exit block occurred in 92%. Myocardial thickness did not differ between patients with or without perforation. In 96%, the perforation was treated by transvenous withdrawal.
Chest pain, phrenic stimulation, bad sensing, or exit block early after PM implantation must prompt radiological and echocardiographic evaluation. A missing pericardial effusion particularly late after implantation does not rule out a perforation. Especially active fixating leads have a higher risk of perforation. With cardiac surgery in standby transvenous withdrawal is a safe way to treat lead perforation.
术后导线穿孔是心脏起搏的一种危及生命的并发症。识别这种严重并发症的诱发因素可能有助于预测特定的风险特征并降低其发生率。
我们进行了一项回顾性三级转诊中心分析,以阐明与起搏器(PM)和心脏复律除颤器导线穿孔相关的临床、解剖和技术特征。我们检查了基线特征和症状。在一个亚组中,我们通过对比增强心脏计算机断层扫描研究了心肌厚度。
我们纳入了26例患者。女性似乎使患者发生导线穿孔的风险略有增加。大多数患者使用的是主动固定导线。72%的患者出现了症状。心包积液和心包填塞分别占38%和19%。65%的患者感知功能受损。92%的患者出现高起搏阈值或出口阻滞。有穿孔和无穿孔患者的心肌厚度无差异。96%的穿孔通过经静脉取出导线进行治疗。
PM植入后早期出现胸痛、膈神经刺激、感知不良或出口阻滞必须促使进行放射学和超声心动图评估。尤其是植入后晚期没有心包积液并不能排除穿孔。特别是主动固定导线穿孔风险较高。对于随时可能进行心脏手术的患者,经静脉取出导线是治疗导线穿孔的一种安全方法。